Home » Topics » BioWorld Science

BioWorld Science
RSS

GT Biopharma initiates enrollment in first-in-human study of GTB-3550

Sep. 13, 2019

Wharton's jelly-derived mesenchymal stem cells evaluated in chronic ischemic heart failure

Sep. 13, 2019

Bug likes bleach

Sep. 13, 2019

In vivo research suggests E-cadherin drives metastasis

Sep. 13, 2019

Moderna offers phase I data from chikungunya and CMV programs

Sep. 12, 2019

Prevail Therapeutics advances development of PR-001 for Parkinson's and Gaucher's diseases

Sep. 12, 2019

Adverum reports 24-week cohort 1 data from phase I study of ADVM-022 in wet AMD

Sep. 12, 2019

Tubulis enters collaboration with Glycotope for development of novel ADC therapy

Sep. 12, 2019

Ocrelizumab in RRMS: CASTING study phase III results presented

Sep. 12, 2019

Glioblastoma stem cells co-opt circadian pacemakers

Sep. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...